Technology | April 23, 2013

Nucletron Debuts Flexitron Brachytherapy Afterloading Platform

New features hope to optimize the treatment delivery process

April 23, 2013 — Nucletron, an Elekta company, has introduced its redesigned Flexitron remote afterloading platform. Flexitron emphasizes safety and efficiency in the brachytherapy workflow, increasing the clinician's confidence that execution of all workflow steps will proceed as planned for brachytherapy/treatment delivery.

Key to the new Flexitron are advances to optimize the treatment delivery process. One of these features is an intuitive layout that efficiently leads the user through the treatment delivery workflow. Flexitron also includes transfer tubes that all are of the same 1000 mm length to reduce ambiguity, a "reference zero" at the entrance of the catheter, a dwell position number that directly reflects the dwell position distance and forward stepping source positioning.

Flexitron features scalable configurations with 10, 20 or 40 channels and is compatible with Nucletron applicators, Oncentra Brachy and the HDR Real-Time Prostate Solution.

For more information: www.nucletron.com

Related Content

California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017
iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct intraoperative radiation...
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
Proton Therapy Shows Promising Clinical Benefits for Esophageal, Prostate and Breast Cancer
News | Proton Therapy | October 30, 2017
The National Association for Proton Therapy (NAPT) announced a number of clinical papers showing promising results were...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
Overlay Init